Modulation of immune response

"Modulation of immune response" is not a specific molecule or receptor but rather a broad therapeutic strategy that encompasses various approaches to alter the activity and balance within the immune system. This can involve enhancing or suppressing different components such as cytokines, receptors (like CTLA‑4 and PD‑1), signaling pathways, and cellular responses. The goal is often to restore homeostasis in diseases characterized by an overactive or underactive immune system—such as autoimmune disorders, cancer, infections, and neuroinflammatory conditions. Numerous drugs—including interferons and monoclonal antibodies—are used to achieve these effects through diverse mechanisms like cytokine regulation and checkpoint inhibition. However, because "modulation of immune response" does not refer to a single molecular entity but rather an entire class of interventions targeting multiple molecules across the immune network, it should not be considered a canonical therapeutic target itself; instead it describes a pharmacological approach encompassing many distinct targets.[1][3][6]

Other names

Immune modulationImmunomodulationModulation of the immune system

Regulation of cytokine release balance; Inhibition or activation of T-cell function; Blockade or stimulation of immune checkpoints (e.g., CTLA‑4, PD‑1/PD-L1)